NIH-funded research R01 grant

Investigating how sleep apnea affects blood vessel health and aging

Official title: p16 Cellular Senescence and Vascular Dysfunction in Sleep Apnea

Funded at University of Kansas Medical Center · NIH-11319450 · Data updated 2026-11-12

This study is looking at how obstructive sleep apnea affects your blood vessels and might make them age faster, while also checking out a protein called p16 that’s connected to this process, so if you have sleep apnea, your participation could help us understand how it impacts your heart health.

More Sleep Apnea research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startApril 15, 2025
Project endApril 30, 2028
Funding year2025
Award (this year)$749,508
NIH project number7R01HL169266-02
Project IDNIH-11319450 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who have been diagnosed with obstructive sleep apnea.

Less likely to help

Patients without obstructive sleep apnea or those under 21 years old may not benefit from this research.

What this research studies

This research focuses on understanding the impact of obstructive sleep apnea (OSA) on blood vessel health and how it may accelerate biological aging. The study aims to explore the role of a specific protein, p16, which is linked to cellular aging and dysfunction in blood vessels. By examining the effects of intermittent hypoxia caused by OSA, the researchers hope to uncover the mechanisms behind vascular senescence and its implications for cardiovascular health. Patients may be involved in assessments that help identify the relationship between sleep apnea and vascular aging.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve vascular health and reduce cardiovascular risks for patients with sleep apnea.

How similar studies have gone: Previous research has shown promising results in targeting cellular senescence to improve health outcomes, suggesting potential for success in this novel approach.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Cortese, Rene Gabriel — University of Kansas Medical Center
  • Study coordinator: Cortese, Rene Gabriel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.